Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2013 1
2014 3
2015 1
2016 2
2018 1
2019 5
2020 3
2021 2
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an American Society for Radiation Oncology Clinical Practice Guideline.
Likhacheva A, Awan M, Barker CA, Bhatnagar A, Bradfield L, Brady MS, Buzurovic I, Geiger JL, Parvathaneni U, Zaky S, Devlin PM. Likhacheva A, et al. Pract Radiat Oncol. 2020 Jan-Feb;10(1):8-20. doi: 10.1016/j.prro.2019.10.014. Epub 2019 Dec 9. Pract Radiat Oncol. 2020. PMID: 31831330
PURPOSE: This guideline reviews the evidence for the use of definitive and postoperative radiation therapy (RT) in patients with basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC). ...The guideline also recommends aga …
PURPOSE: This guideline reviews the evidence for the use of definitive and postoperative radiation therapy (RT) in patients with basa …
Update of the Management of Cutaneous Squamous-cell Carcinoma.
Maubec E. Maubec E. Acta Derm Venereol. 2020 Jun 3;100(11):adv00143. doi: 10.2340/00015555-3498. Acta Derm Venereol. 2020. PMID: 32346744 Free PMC article. Review.
For all primary cutaneous squamous cell carcinomas (cSCCs), physical examination should include full skin examination, recording of tumour diameter and regional lymph-node-basin status. ...In case of positive lymph nodes, radical dissection is needed, with op …
For all primary cutaneous squamous cell carcinomas (cSCCs), physical examination should include full skin examination, …
Optimal treatment of unresectable nonmelanoma skin cancers.
Olencki T. Olencki T. J Natl Compr Canc Netw. 2014 May;12(5 Suppl):789-92. doi: 10.6004/jnccn.2014.0191. J Natl Compr Canc Netw. 2014. PMID: 24853218 Review.
Unlike in other types of cancer, in metastatic nonmelanoma, there are few dedicated oncologists to care for patients with unresectable skin cancers and little reliable clinical evidence to craft a therapeutic strategy. In his presentation at the NCCN 1 …
Unlike in other types of cancer, in metastatic nonmelanoma, there are few dedicated oncologists to care for patients with unresect …
Immune checkpoint inhibitors for treatment of periorbital squamous cell carcinoma.
Goldfarb JA, Ferrarotto R, Gross N, Goepfert R, Debnam JM, Gunn B, Nagarajan P, Esmaeli B. Goldfarb JA, et al. Br J Ophthalmol. 2023 Mar;107(3):320-323. doi: 10.1136/bjophthalmol-2021-319417. Epub 2021 Oct 8. Br J Ophthalmol. 2023. PMID: 34625433
PURPOSE: To report on the outcomes of immunotherapy in patients with locally advanced periorbital squamous cell carcinoma. METHODS: We performed a retrospective chart review of seven consecutive patients with locally advanced periorbital cutaneous squamous …
PURPOSE: To report on the outcomes of immunotherapy in patients with locally advanced periorbital squamous cell carcinoma …
Local Chemotherapy as an Adjuvant Treatment in Unresectable Squamous Cell Carcinoma: What Do We Know So Far?
Bennardo L, Bennardo F, Giudice A, Passante M, Dastoli S, Morrone P, Provenzano E, Patruno C, Nisticò SP. Bennardo L, et al. Curr Oncol. 2021 Jun 23;28(4):2317-2325. doi: 10.3390/curroncol28040213. Curr Oncol. 2021. PMID: 34201867 Free PMC article. Review.
Background: Squamous cell carcinoma (SCC) is one of the most common cancers involving skin and oral mucosa. Although this condition's gold-standard treatment is the surgical removal of the lesions, the physician must propose alternative treatments in s …
Background: Squamous cell carcinoma (SCC) is one of the most common cancers involving skin and oral mucosa. Alth …
Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma.
Hernández-Guerrero T, Doger B, Moreno V. Hernández-Guerrero T, et al. Drugs Today (Barc). 2019 Aug;55(8):485-494. doi: 10.1358/dot.2019.55.8.3005176. Drugs Today (Barc). 2019. PMID: 31461085
Cutaneous squamous cell carcinoma (cSCC) is the second most frequent type of malignancy in Caucasians worldwide. ...Recently, it has been recognized that cSCCs are highly mutated tumors with a denoting potential likelihood of response to immune checkpoint blo …
Cutaneous squamous cell carcinoma (cSCC) is the second most frequent type of malignancy in Caucasians worldwide. ...Rec …
Stage IV cutaneous squamous cell carcinoma: treatment outcomes in a series of 42 patients.
Chapalain M, Baroudjian B, Dupont A, Lhote R, Lambert J, Bagot M, Lebbe C, Basset-Seguin N. Chapalain M, et al. J Eur Acad Dermatol Venereol. 2020 Jun;34(6):1202-1209. doi: 10.1111/jdv.16007. Epub 2019 Oct 6. J Eur Acad Dermatol Venereol. 2020. PMID: 31587382
BACKGROUND: The prevalence and incidence of cutaneous squamous cell carcinoma (cSCC) are increasing due to the ageing of the population and sun exposure. ...OBJECTIVE: Analysis of the clinical characteristics and treatment outcomes in stage IV cSCC with un …
BACKGROUND: The prevalence and incidence of cutaneous squamous cell carcinoma (cSCC) are increasing due to the ageing o …
The role of targeted molecular inhibitors in the management of advanced nonmelanoma skin cancer.
O'Bryan KW, Ratner D. O'Bryan KW, et al. Semin Cutan Med Surg. 2011 Mar;30(1):57-61. doi: 10.1016/j.sder.2011.01.004. Semin Cutan Med Surg. 2011. PMID: 21540021 Review.
Surgical treatment remains the standard of care for nonmelanoma skin cancer and is successful for the vast majority of patients with these tumors. ...In this review, we seek to illuminate recent developments and future possibilities in the use of targeted molecular …
Surgical treatment remains the standard of care for nonmelanoma skin cancer and is successful for the vast majority of patient …
Treatment of unresectable and metastatic cutaneous squamous cell carcinoma.
Cranmer LD, Engelhardt C, Morgan SS. Cranmer LD, et al. Oncologist. 2010;15(12):1320-8. doi: 10.1634/theoncologist.2009-0210. Epub 2010 Dec 8. Oncologist. 2010. PMID: 21147868 Free PMC article.
Cutaneous squamous cell carcinoma (SCC) is an already common disorder with a rapidly increasing incidence. Treatment of early disease depends primarily on surgery or destructive techniques. In contrast to the frequency of early SCC, unresectable or met …
Cutaneous squamous cell carcinoma (SCC) is an already common disorder with a rapidly increasing incidence. Treatment of …
Cetuximab-radiotherapy combination in the management of locally advanced cutaneous squamous cell carcinoma.
Joseph K, Alkaabi K, Warkentin H, Ghosh S, Jha N, Smylie M, Walker J. Joseph K, et al. J Med Imaging Radiat Oncol. 2019 Apr;63(2):257-263. doi: 10.1111/1754-9485.12842. Epub 2018 Dec 14. J Med Imaging Radiat Oncol. 2019. PMID: 30549229
INTRODUCTION: We report the outcomes of using a combination of cetuximab with radiation therapy (Cetux-RT) to treat a selected group of patients with locally advanced (unresectable) cutaneous squamous cell carcinoma (LA-cSCC). ...
INTRODUCTION: We report the outcomes of using a combination of cetuximab with radiation therapy (Cetux-RT) to treat a selected group …
19 results